Loading…

Granulovacuolar degeneration: a neurodegenerative change that accompanies tau pathology

Granule-containing vacuoles in the cytoplasm of hippocampal neurons are a neuropathological feature of Alzheimer’s disease. Granulovacuolar degeneration (GVD) is not disease-specific and can be observed in other neurodegenerative disorders and even in the brains of non-demented elderly people. Howev...

Full description

Saved in:
Bibliographic Details
Published in:Acta neuropathologica 2016-09, Vol.132 (3), p.339-359
Main Author: Kohler, Christoph
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c472t-27633546b7980bae66da45902c4960a84583fbeefaa7101ca29b4e8a7d26d2783
cites cdi_FETCH-LOGICAL-c472t-27633546b7980bae66da45902c4960a84583fbeefaa7101ca29b4e8a7d26d2783
container_end_page 359
container_issue 3
container_start_page 339
container_title Acta neuropathologica
container_volume 132
creator Kohler, Christoph
description Granule-containing vacuoles in the cytoplasm of hippocampal neurons are a neuropathological feature of Alzheimer’s disease. Granulovacuolar degeneration (GVD) is not disease-specific and can be observed in other neurodegenerative disorders and even in the brains of non-demented elderly people. However, several studies have reported much higher numbers of neurons undergoing GVD in the hippocampus of Alzheimer’s disease cases. Recently, a neuropathological staging system for GVD has facilitated neuropathological assessment. Data obtained by electron microscopy and immunolabeling suggest that GVD inclusions are a special form of autophagic vacuole. GVD frequently occurs together with pathological changes of the microtubule-associated protein tau, but to date, the relationship between the two lesions remains elusive. Originally identified in hematoxylin- and silver-stained sections, immunolabeling has shown that the granules are composed of a variety of proteins, including those related to tau pathology, autophagy, diverse signal transduction pathways, cell stress and apoptosis. Several of these proteins serve as markers of GVD. Most researchers and authors have interpreted the sequestration of proteins into GVD inclusions as either a cellular defense mechanism or one that leads to the impairment of important cellular functions. This review provides a detailed overview of the various aspects of GVD and focuses on the relationship between tau pathology and GVD.
doi_str_mv 10.1007/s00401-016-1562-0
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1815699782</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A470430926</galeid><sourcerecordid>A470430926</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-27633546b7980bae66da45902c4960a84583fbeefaa7101ca29b4e8a7d26d2783</originalsourceid><addsrcrecordid>eNqNkU1v1DAQhi0EokvhB3BBkbhwSRl_xHa4VRUUpEpcQBytiTPZTZXYi51U6r_HyxYKCCTkgz0zzzua8cvYcw5nHMC8zgAKeA1c17zRooYHbMOVLI9GyodsA1CqWgpxwp7kfF0iYVTzmJ0IA1oIDRv25TJhWKd4g36NE6aqpy0FSriMMbypsAq0pnifvKHK7zBsqVp2uFTofZz3GEbK1YJrtcdlF6e4vX3KHg04ZXp2d5-yz-_efrp4X199vPxwcX5Ve2XEUgujpWyU7kxroUPSukfVtCC8ajWgVY2VQ0c0IBoO3KNoO0UWTS90L4yVp-zVse8-xa8r5cXNY_Y0TRgortlxW36mbY0V_4MKW3AFBX35B3od1xTKIt8pDaJt7D21xYncGIa4JPSHpu5cGVASWqELdfYXqpye5tHHQMNY8r8J-FHgU8w50eD2aZwx3ToO7uC7O_ruiu_u4Ls7DPzibuC1m6n_qfhhdAHEEcilVOxLv2z0z67fADwbtXg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1812602958</pqid></control><display><type>article</type><title>Granulovacuolar degeneration: a neurodegenerative change that accompanies tau pathology</title><source>Springer Link</source><creator>Kohler, Christoph</creator><creatorcontrib>Kohler, Christoph</creatorcontrib><description>Granule-containing vacuoles in the cytoplasm of hippocampal neurons are a neuropathological feature of Alzheimer’s disease. Granulovacuolar degeneration (GVD) is not disease-specific and can be observed in other neurodegenerative disorders and even in the brains of non-demented elderly people. However, several studies have reported much higher numbers of neurons undergoing GVD in the hippocampus of Alzheimer’s disease cases. Recently, a neuropathological staging system for GVD has facilitated neuropathological assessment. Data obtained by electron microscopy and immunolabeling suggest that GVD inclusions are a special form of autophagic vacuole. GVD frequently occurs together with pathological changes of the microtubule-associated protein tau, but to date, the relationship between the two lesions remains elusive. Originally identified in hematoxylin- and silver-stained sections, immunolabeling has shown that the granules are composed of a variety of proteins, including those related to tau pathology, autophagy, diverse signal transduction pathways, cell stress and apoptosis. Several of these proteins serve as markers of GVD. Most researchers and authors have interpreted the sequestration of proteins into GVD inclusions as either a cellular defense mechanism or one that leads to the impairment of important cellular functions. This review provides a detailed overview of the various aspects of GVD and focuses on the relationship between tau pathology and GVD.</description><identifier>ISSN: 0001-6322</identifier><identifier>EISSN: 1432-0533</identifier><identifier>DOI: 10.1007/s00401-016-1562-0</identifier><identifier>PMID: 27062260</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Alzheimer Disease - metabolism ; Alzheimer Disease - pathology ; Alzheimer's disease ; Animals ; Brain ; Cellular signal transduction ; Hippocampus - metabolism ; Hippocampus - pathology ; Humans ; Medicine ; Medicine &amp; Public Health ; Nerve Degeneration - pathology ; Nervous system diseases ; Neurons - metabolism ; Neurons - pathology ; Neurosciences ; Pathology ; Physiological aspects ; Proteins ; Review ; tau Proteins - metabolism ; Vacuoles - metabolism</subject><ispartof>Acta neuropathologica, 2016-09, Vol.132 (3), p.339-359</ispartof><rights>Springer-Verlag Berlin Heidelberg 2016</rights><rights>COPYRIGHT 2016 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-27633546b7980bae66da45902c4960a84583fbeefaa7101ca29b4e8a7d26d2783</citedby><cites>FETCH-LOGICAL-c472t-27633546b7980bae66da45902c4960a84583fbeefaa7101ca29b4e8a7d26d2783</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>313,314,776,780,788,27901,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27062260$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kohler, Christoph</creatorcontrib><title>Granulovacuolar degeneration: a neurodegenerative change that accompanies tau pathology</title><title>Acta neuropathologica</title><addtitle>Acta Neuropathol</addtitle><addtitle>Acta Neuropathol</addtitle><description>Granule-containing vacuoles in the cytoplasm of hippocampal neurons are a neuropathological feature of Alzheimer’s disease. Granulovacuolar degeneration (GVD) is not disease-specific and can be observed in other neurodegenerative disorders and even in the brains of non-demented elderly people. However, several studies have reported much higher numbers of neurons undergoing GVD in the hippocampus of Alzheimer’s disease cases. Recently, a neuropathological staging system for GVD has facilitated neuropathological assessment. Data obtained by electron microscopy and immunolabeling suggest that GVD inclusions are a special form of autophagic vacuole. GVD frequently occurs together with pathological changes of the microtubule-associated protein tau, but to date, the relationship between the two lesions remains elusive. Originally identified in hematoxylin- and silver-stained sections, immunolabeling has shown that the granules are composed of a variety of proteins, including those related to tau pathology, autophagy, diverse signal transduction pathways, cell stress and apoptosis. Several of these proteins serve as markers of GVD. Most researchers and authors have interpreted the sequestration of proteins into GVD inclusions as either a cellular defense mechanism or one that leads to the impairment of important cellular functions. This review provides a detailed overview of the various aspects of GVD and focuses on the relationship between tau pathology and GVD.</description><subject>Alzheimer Disease - metabolism</subject><subject>Alzheimer Disease - pathology</subject><subject>Alzheimer's disease</subject><subject>Animals</subject><subject>Brain</subject><subject>Cellular signal transduction</subject><subject>Hippocampus - metabolism</subject><subject>Hippocampus - pathology</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Nerve Degeneration - pathology</subject><subject>Nervous system diseases</subject><subject>Neurons - metabolism</subject><subject>Neurons - pathology</subject><subject>Neurosciences</subject><subject>Pathology</subject><subject>Physiological aspects</subject><subject>Proteins</subject><subject>Review</subject><subject>tau Proteins - metabolism</subject><subject>Vacuoles - metabolism</subject><issn>0001-6322</issn><issn>1432-0533</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqNkU1v1DAQhi0EokvhB3BBkbhwSRl_xHa4VRUUpEpcQBytiTPZTZXYi51U6r_HyxYKCCTkgz0zzzua8cvYcw5nHMC8zgAKeA1c17zRooYHbMOVLI9GyodsA1CqWgpxwp7kfF0iYVTzmJ0IA1oIDRv25TJhWKd4g36NE6aqpy0FSriMMbypsAq0pnifvKHK7zBsqVp2uFTofZz3GEbK1YJrtcdlF6e4vX3KHg04ZXp2d5-yz-_efrp4X199vPxwcX5Ve2XEUgujpWyU7kxroUPSukfVtCC8ajWgVY2VQ0c0IBoO3KNoO0UWTS90L4yVp-zVse8-xa8r5cXNY_Y0TRgortlxW36mbY0V_4MKW3AFBX35B3od1xTKIt8pDaJt7D21xYncGIa4JPSHpu5cGVASWqELdfYXqpye5tHHQMNY8r8J-FHgU8w50eD2aZwx3ToO7uC7O_ruiu_u4Ls7DPzibuC1m6n_qfhhdAHEEcilVOxLv2z0z67fADwbtXg</recordid><startdate>20160901</startdate><enddate>20160901</enddate><creator>Kohler, Christoph</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20160901</creationdate><title>Granulovacuolar degeneration: a neurodegenerative change that accompanies tau pathology</title><author>Kohler, Christoph</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-27633546b7980bae66da45902c4960a84583fbeefaa7101ca29b4e8a7d26d2783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Alzheimer Disease - metabolism</topic><topic>Alzheimer Disease - pathology</topic><topic>Alzheimer's disease</topic><topic>Animals</topic><topic>Brain</topic><topic>Cellular signal transduction</topic><topic>Hippocampus - metabolism</topic><topic>Hippocampus - pathology</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Nerve Degeneration - pathology</topic><topic>Nervous system diseases</topic><topic>Neurons - metabolism</topic><topic>Neurons - pathology</topic><topic>Neurosciences</topic><topic>Pathology</topic><topic>Physiological aspects</topic><topic>Proteins</topic><topic>Review</topic><topic>tau Proteins - metabolism</topic><topic>Vacuoles - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kohler, Christoph</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Acta neuropathologica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kohler, Christoph</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Granulovacuolar degeneration: a neurodegenerative change that accompanies tau pathology</atitle><jtitle>Acta neuropathologica</jtitle><stitle>Acta Neuropathol</stitle><addtitle>Acta Neuropathol</addtitle><date>2016-09-01</date><risdate>2016</risdate><volume>132</volume><issue>3</issue><spage>339</spage><epage>359</epage><pages>339-359</pages><issn>0001-6322</issn><eissn>1432-0533</eissn><abstract>Granule-containing vacuoles in the cytoplasm of hippocampal neurons are a neuropathological feature of Alzheimer’s disease. Granulovacuolar degeneration (GVD) is not disease-specific and can be observed in other neurodegenerative disorders and even in the brains of non-demented elderly people. However, several studies have reported much higher numbers of neurons undergoing GVD in the hippocampus of Alzheimer’s disease cases. Recently, a neuropathological staging system for GVD has facilitated neuropathological assessment. Data obtained by electron microscopy and immunolabeling suggest that GVD inclusions are a special form of autophagic vacuole. GVD frequently occurs together with pathological changes of the microtubule-associated protein tau, but to date, the relationship between the two lesions remains elusive. Originally identified in hematoxylin- and silver-stained sections, immunolabeling has shown that the granules are composed of a variety of proteins, including those related to tau pathology, autophagy, diverse signal transduction pathways, cell stress and apoptosis. Several of these proteins serve as markers of GVD. Most researchers and authors have interpreted the sequestration of proteins into GVD inclusions as either a cellular defense mechanism or one that leads to the impairment of important cellular functions. This review provides a detailed overview of the various aspects of GVD and focuses on the relationship between tau pathology and GVD.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>27062260</pmid><doi>10.1007/s00401-016-1562-0</doi><tpages>21</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0001-6322
ispartof Acta neuropathologica, 2016-09, Vol.132 (3), p.339-359
issn 0001-6322
1432-0533
language eng
recordid cdi_proquest_miscellaneous_1815699782
source Springer Link
subjects Alzheimer Disease - metabolism
Alzheimer Disease - pathology
Alzheimer's disease
Animals
Brain
Cellular signal transduction
Hippocampus - metabolism
Hippocampus - pathology
Humans
Medicine
Medicine & Public Health
Nerve Degeneration - pathology
Nervous system diseases
Neurons - metabolism
Neurons - pathology
Neurosciences
Pathology
Physiological aspects
Proteins
Review
tau Proteins - metabolism
Vacuoles - metabolism
title Granulovacuolar degeneration: a neurodegenerative change that accompanies tau pathology
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T06%3A34%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Granulovacuolar%20degeneration:%20a%20neurodegenerative%20change%20that%20accompanies%20tau%20pathology&rft.jtitle=Acta%20neuropathologica&rft.au=Kohler,%20Christoph&rft.date=2016-09-01&rft.volume=132&rft.issue=3&rft.spage=339&rft.epage=359&rft.pages=339-359&rft.issn=0001-6322&rft.eissn=1432-0533&rft_id=info:doi/10.1007/s00401-016-1562-0&rft_dat=%3Cgale_proqu%3EA470430926%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c472t-27633546b7980bae66da45902c4960a84583fbeefaa7101ca29b4e8a7d26d2783%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1812602958&rft_id=info:pmid/27062260&rft_galeid=A470430926&rfr_iscdi=true